イチバ　シンゴ   Ichiba Shingo   市場　晋吾    所属   医学部 医学科（東京女子医科大学病院）    職種   教授
論文種別	総説
言語種別	英語
査読の有無	査読あり
表題	Current status of extracorporeal membrane oxygenation for severe respiratory failure.
掲載誌名	正式名：Artificial organs 略　 称：Artif Organs ISSNコード：0160564X/0160564X
掲載区分	国外
巻・号・頁	20(2),pp.120-123
著者・共著者	Ichiba S, Bartlett R H
発行年月	1996/02
概要	Extracorporeal membrane oxygenation (ECMO) for respiratory failure was reviewed. ECMO progressed from laboratory research to initial clinical trials in 1972. Following a decade of clinical research, ECMO is now standard treatment for neonatal respiratory failure refractory to conventional pulmonary support techniques worldwide. The application of neonatal ECMO has been extended with improved outcome to premature and low birth weight infants as well as older children and adults. As of July 1994, 9,258 neonates, 754 pediatric, and 130 adult patients with respiratory failure treated with ECMO were entered in the registry of the Extracorporeal Life Support Organization (ELSO). Overall survival rates were 81% in neonates, 49% in pediatric, and 38% in adult patients. Recently the adult and pediatric populations treated with ECMO have increased rapidly, and the outcome has improved significantly.
DOI	10.1111/j.1525-1594.1996.tb00712.x
PMID	8712954